OMICS 2.0: A practice turn for 21st century science and society

OMICS A Journal of Integrative Biology

Volumn 17, Issue 1, 2013, Pages 1-4

  Özdemir, Vural ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Data Enabled Life Sciences Alliance International DELSA Global   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; BIOTECHNOLOGY; GENOMICS; MEDICAL LITERATURE; MEDICAL RESEARCH; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; TRANSLATIONAL RESEARCH;

AGRICULTURE; GENOMICS; METABOLOMICS; NUTRIGENOMICS; PROTEOMICS; PUBLIC HEALTH;

EID: 84872188213     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2012.0111     Document Type: Review

References (31)

1. Burke W, and Trinidad SB. (2011). Systems medicine and the public's health. Genome Med 3, 47.
2. Collins FS. (2011). Reengineering translational science: The time is right. Sci Transl Med 3, 90cm17.
3. Dove ES, Faraj SA, Kolker E, and Özdemir V. (2012). Designing a post-genomics knowledge ecosystem to translate pharmacogenomics to public health action. Genome Med 4, 91.
4. Dove ES, and Özdemir V. (2012). 'Regular science' is inherently political. EMBO Rep (in press).
5. Faraj SA, Kolker E, Bevilacqua L, and O? zdemir V. (2012). Collective theranostics and postgenomics entrepreneurship: Rethinking innovations as knowledge ecosystems built by complex collaboration. Expert Rev Mol Diagn 12(8) (in press).
6. Gibbons M. (1997). 1997 Beanland Lecture. What Kind of University? Research and Teaching in the 21st Century. Melbourne: Victoria University of Technology.
7. Guston DH. (1992). The demise of the social contract for science. Misconduct in science and the nonmodern world. In: Program in Science, Technology, and Society. Massachusetts Institute of Technology. Working paper number 19, 1992. Available from: http://web.mit.edu/STS/pubs/pdfs/MIT-STS- WorkingPaper-19-Guston-2.pdf Accessed November 15, 2012.
8. Harvey A, Brand A, Holgate ST, Kristiansen LV, Lehrach H, Palotie A, and Prainsack B. (2012). The future of technologies for personalised medicine. N Biotechnol 29, 625-633.
9. Hotez PJ, and Gurwith M. (2011). Europe's neglected infections of poverty. Int J Infect Dis 15, e611-619.
10. Hotez PJ, Bottazzi ME, Dumonteil E, et al., (2012). Texas and Mexico: Sharing a legacy of poverty and neglected tropical diseases. PLoS Negl Trop Dis 6, e1497.
11. Huzair F, Borda-Rodriguez A, and Upton M. (2011). Twentyfirst century vaccinomics innovation systems: Capacity building in the global South and the role of Product Development Partnerships (PDPs). OMICS 15, 539-543.
12. Jasanoff S. (2007). Technologies of humility. Nature 450, 33. (Pubitemid 350070552)
13. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, and Bradley L. (2007). The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 9, 665-674. (Pubitemid 350287151)
14. Kickbusch I. (2005). Tackling the political determinants of global health. BMJ 331, 246-247. (Pubitemid 41097904)
15. Knoppers BM, and Ozdemir V. (2013). Biogenetics and the concept of humanity. In: Research Project in Humanity. Van Beers B.B. (Ed.) Cambridge: Cambridge University Press (in press).
16. Kolker E. (2012). OMICS transition. OMICS, 16(12), 637
17. Lederberg J, and McCray AT. (2001). "Ome sweet omics"-A genealogical treasury of words. Scientist 15, 2.
18. Micheel CM, Nass SJ, and Omenn GS. (2012). Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington DC: National Academies Press.
19. Orlikowsky W. (2002). Knowing in practice: Enacting a collective capability in distributed organizing. Org Sci 13, 249-273.
20. Orlikowski WJ. (2009). The sociomateriality of organisational life: Considering technology in management research. Cambridge J Econ 34, 125-141.
21. Ostrom E. (1990). Governing the Commons: The Evolution of Institutions for Collective Action. Cambridge: Cambridge University Press.
22. Ozdemir V, Suarez-Kurtz G, Stenne R, et al. (2009). Risk assessment and communication tools for genotype associations with multifactorial phenotypes: The concept of "edge effect" and cultivating an ethical bridge between omics innovations and society. OMICS 13, 43-61.
23. Ozdemir V, Pang T, Knoppers BM, et al. (2011). Vaccines of the 21st century and vaccinomics: Data-enabled science meets global health to spark collective action for vaccine innovation. OMICS 15, 523-527.
24. Ozdemir V, and Cho WCS. (2012). Theranostics: Rethinking postgenomics diagnostics. Expert Rev Mol Diag 12(8) (in press).
25. Pang T. (2012). Theranostics, the 21st century bioeconomy and 'one health'. Interview with Vural O? zdemir (McGill University, QC, Canada) and Edward S Dove (Columbia University, NY, USA). Expert Rev Mol Diag 12(8), (in press).
26. Prainsack B. (2012). Direct-To-consumer theranostics, 21st century collective innovation and entrepreneurship. Interview with Vural O? zdemir (McGill University, QC, Canada) and Edward S Dove (Columbia University, NY, USA). Expert Rev Mol Diag 12(8), (in press).
27. Rose N. (2006). The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-First Century. Princeton: Princeton University Press.
28. Suresh S. (2012). Cultivating global science. Science 336, 959.
29. Wynne B. (2009). Daring to imagine. India Seminars. Available from: http://www.india-seminar.com/2009/597/597-brian-wynne.htm Accessed November 15, 2012.
30. Wynne B. (2011). Lab work goes social, and vice versa: Strategising public engagement processes: Commentary on: "What happens in the lab does not stay in the lab: Applying midstream modulation to enhance critical reflection in the laboratory". Sci Eng Ethics 17, 791-800.
31. Zimmern RL, and Khoury MJ. (2012). The impact of genomics on public health practice: The case for change. Public Health Genomics 15, 118-124.